A thiosemicarbazone-based dinuclear copper(II) complex: potent antiproliferative activity, distinct cell-type-specific anticancer mechanisms and robust in vivo antitumor efficacy
- 12 May 2026
- journal article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 179, 109981
Abstract
No abstract availableKeywords
Funding Information
- Shanxi Scholarship Council of China (2023-004 & 2023-018)
- Natural Science Foundation of Shanxi Province (202303021212361)
- Natural Science Foundation of Shanxi Province (202303021211017)
- National Natural Science Foundation of China (22475124)
- National Natural Science Foundation of China (22573061)
This publication has 61 references indexed in Scilit:
- In vitro and in vivo antiproliferative activity on lung cancer of two acylhydrazone based zinc(II) complexesBioorganic Chemistry, 2024
- Riding the metal wave: A review of the latest developments in metal-based anticancer agentsCoordination Chemistry Reviews, 2023
- A novel water-soluble thiosemicarbazone Schiff base ligand and its complexes as potential anticancer agents and cellular fluorescence imagingJBIC Journal of Biological Inorganic Chemistry, 2023
- Cu-related agents for cancer therapiesCoordination Chemistry Reviews, 2023
- Recent Development of Copper (II) Complexes of Polypyridyl Ligands in Chemotherapy and Photodynamic TherapyChemMedChem, 2023
- Anticancer Activity and Mechanism of Action Evaluation of an Acylhydrazone Cu(II) Complex toward Breast Cancer Cells, Spheroids, and MammospheresChemMedChem, 2021
- Synthesis and anti-proliferative activity of allogibberic acid derivatives containing 1,2,3-triazole pharmacophoreBioorganic & Medicinal Chemistry Letters, 2018
- Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agentsCancer and Metastasis Reviews, 2017
- Human topoisomerase IB is a target of a thiosemicarbazone copper(II) complexArchives of Biochemistry and Biophysics, 2016
- Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cellsBiochemical Pharmacology, 2004